Genomic Health, Inc.
(NASDAQ : GHDX)

( )
GHDX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
GHGuardant Health, Inc. 0.00%72.000.0%$80.88m
NTRANatera, Inc. 0.00%61.171.1%$70.20m
DVADaVita, Inc. -0.04%109.623.8%$62.67m
NVTAInvitae Corp. 1.44%11.311.1%$52.55m
OSHOak Street Health, Inc. 5.78%20.500.0%$51.00m
SBEVSplash Beverage Group, Inc. -7.98%3.690.0%$42.63m
AMEDAmedisys, Inc. 0.00%133.0211.4%$40.42m
FLGTFulgent Genetics, Inc. 0.01%69.250.6%$35.35m
APRApria, Inc. 0.00%37.180.0%$33.20m
ONEM1Life Healthcare, Inc. 0.00%11.140.0%$31.85m
LHCGLHC Group, Inc. 0.00%122.362.9%$31.35m
AGLAgilon Health, Inc. -0.06%16.890.0%$31.31m
CHEChemed Corp. 0.22%477.0610.5%$24.20m
ACHCAcadia Healthcare Co., Inc. 0.00%53.8026.8%$22.63m
NEONeoGenomics, Inc. 0.00%22.525.1%$19.28m

Company Profile

Genomic Health, Inc. (NASDAQ: GHDX) is a provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.